Results of our studies demonstrate that development of NASH-like lesions in the liver in ApoE−/− mice fed DSS does not require an high fat diet, strongly advocating a regulatory role of the intestinal microbiota on systemic metabolism. The gene discussed is APOE; the disease is metabolic dysfunction-associated steatohepatitis.